Sponsor
Dr Reddy's receives two USFDA observations for New York API facility
Posted
Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
RSP demands probe into bribery audio involving Minister Gupta
KATHMANDU: Rastriya Swatantra Party (RSP) lawmaker Sumana Shrestha has demanded an investigation...
Stock market this week: Key factors expected to influence D-Street - check details
Indian markets concluded the week with losses exceeding 1%, influenced by global tariff...
Amaal reacts to sexual harassment allegations on Anu
Composer Amaal Mallik has addressed the 'Me Too' allegations against his uncle, Anu Malik,...